Featured Speakers

Adi Barzel

President of the Israeli Society for Gene and Cell Therapy (ISGCT), ICLE Conference Chair, Senior lecturer at Tel-Aviv University, Israel

Adi Barzel

President of the Israeli Society for Gene and Cell Therapy (ISGCT), ICLE Conference Chair, Senior lecturer at Tel-Aviv University, Israel

Dirk Busch

MD, Director, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Germany

Dirk Busch

MD, Director, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Germany

Chiara Bonini

MD, Deputy Director, Division of Immunology, Transplantation and Infectious Diseases; Head, Experimental Haematology Unit; Full professor, Vita-Salute San Raffaele University, Italy

Chiara Bonini

MD, Deputy Director, Division of Immunology, Transplantation and Infectious Diseases; Head, Experimental Haematology Unit; Full professor, Vita-Salute San Raffaele University, Italy

Malcolm Brenner

MD, PhD, Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine, USA

Malcolm Brenner

MD, PhD, Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine, USA

Michel Sadelain

MD, PhD, Director, Center for Cell Engineering; Stephen and Barbara Friedman Chair, Memorial Sloan Kettering Cancer Center, USA

Michel Sadelain

MD, PhD, Director, Center for Cell Engineering; Stephen and Barbara Friedman Chair, Memorial Sloan Kettering Cancer Center, USA

Hans Stauss

MD, PhD, Director Institute of Immunity and Transplantation; Co-Director Division of Infection and Immunity University College London; Head Clinical Immunology Royal Free London, NHS Foundation Trust, UK

Hans Stauss

MD, PhD, Director Institute of Immunity and Transplantation; Co-Director Division of Infection and Immunity University College London; Head Clinical Immunology Royal Free London, NHS Foundation Trust, UK

Stan Riddell

MD, Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; Professor, Department of Medicine at the University of Washington, USA

Stan Riddell

MD, Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; Professor, Department of Medicine at the University of Washington, USA

Exhibitors & Sponsors

Expanding the Paradigm of Immuno-Gene Therapy

With ground-breaking clinical success and exponentially growing research leading to FDA approved products, lymphocyte engineering is the way of the future. Be part of it! Join us for the 3rd International Conference on Lymphocyte Engineering - where the world`s health innovators in immuno-gene therapy come together.

The ICLE Advantage

ICLE is one of the cornerstone conferences on lymphocyte engineering. Top quality of the scientific program, perfect networking opportunities and the leading scientists and experts in the field are the main benefits of attending shared by our community members. Join us as we lead the future in lymphocyte engineering.